Overview
Kazutaka Katoh practices practicing medicine in Suita, Japan.
Their clinical expertise encompasses Trichorhinophalangeal Syndrome Type 2, Acrodysostosis, Cornelia De Lange Syndrome, and Neuronal Intranuclear Inclusion Disease (NIID).
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kazutaka Katoh
Is Kazutaka Katoh a top-rated expert for Trichorhinophalangeal Syndrome Type 2?
MediFind is an objective health platform that identifies experts based on real-world data. Kazutaka Katoh is classified as an Experienced expert for Trichorhinophalangeal Syndrome Type 2, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kazutaka Katoh participate in research or clinical trials?
Yes. Kazutaka Katoh has published 33 articles and abstracts on conditions like Trichorhinophalangeal Syndrome Type 2. You can view a list of Kazutaka Katoh's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AcrodysostosisKatoh isExperienced. Learn about Acrodysostosis.
- Cornelia De Lange SyndromeKatoh isExperienced. Learn about Cornelia De Lange Syndrome.
- Neuronal Intranuclear Inclusion Disease (NIID)
- Trichorhinophalangeal Syndrome Type 2